Russian Federation
Abdominal surgery is a well-recognized risk factor for venous thromboembolism (VTE). The aim of the study was to determine the e–cacy and safety of extended pharmacological prophylaxis (EPP) after abdominal surgery to prevent clinically signi†cant VTE after hospital discharge. Material and methods. The obtained materials were studied as part of the pan-European prospective CASCADE study. The analysis was performed in accordance with the STROBE recommendations. Data collection was carried out from January 23 to May 1, 2022. The primary e–cacy outcome was the incidence of VTE after discharge. Visualization (ultrasound Doppler phleboscanning) was performed only in cases of clinical symptoms. The secondary outcome was the incidence of clinically relevant bleeding after discharge. Results. A total of 234 patients were included in the study, including 125 women (53.4%). The median age of patients was 61.0 years. The postoperative incidence of clinically relevant VTE was 1.3% (2 in-hospital patients, and 1 person after discharge). After adjusting for variables using mixed-e—ects logistic regression, the median postoperative VTE incidence was 0.2%. Both in-hospital VTE and bleeding were identi†ed after right hemicolectomy. Clinically signi†cant bleeding after discharge was noted in 2 patients (0.9%) (1 clinically insigni†cant bleeding and 1 clinically signi†cant bleeding). After risk adjustment and accounting for treatment selection bias using propensity score weighting, there was no signi†cant association between EPP and the incidence of post-discharge bleeding. Conclusions. Current clinical guidelines have doubtful validity because they do not re˜ect modern trends in surgery. In modern surgical practice, the incidence of postoperative VTE is low. EPP is safe, but its clinical e–cacy remains questionable. Careful selection of patients for EPP is required.
abdominal surgery, postoperation period, thromboembolism, bleeding, anticoagulants
1. Lavikainen L. I., Guyatt G. H., Sallinen V. J., et al. Systematic reviews and meta-analyses of the procedure-specific risks of thrombosis and bleeding in general abdominal, colorectal, upper gastrointestinal, and
2. Thereaux J., Badic B., Fuchs B., et al. From early risk to 1-year mortality: a comprehensive assessment of postoperative venous thromboembolism in upper gastrointestinal cancer patients — a nationwide cohort study. Int J
3. Anderson D. R., Morgano G. P., Bennett C., et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood
4. URL: https://oncology.ru/ specialist/treatment/symptomatic/thromboembolic_disorders/recommendations.pdf. 05.04.2025
5. Rossiyskie klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike venoznyh tromboembolicheskih oslozhneniy. Flebologiya. 2014;4(2):3-52.
6. Kakkar V. V., Balibrea J. L., MartínezGonzález J., Prandoni P. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized
7. Marchocki Z., Norris L., O’Toole S., Gleeson N., Saadeh F. A. Patients’ experience and compliance with extended low EuroSurg Collaborative and STARSurg Collaborative 17. Int J Gynecol Cancer 2019;29:802-809.
8. Student Audit and Research in Surgery (STARSurg) Collaborative and European Surgical (EuroSurg) Collaborative. CArdiovaSCulAr outcomes after major abDominal surgEry: study protocol for a multicentre, observational,
9. von Elm E., Altman D. G., Egger M., et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-349.
10. European Medicines Agency Committee for Medicinal Products for Human Use. Guideline on Clinical Investigation of Medicinal Products for Prevention of Venous Thromboembolism (VTE) in Patients Undergoing High VTE-
11. Bupa. Bupa Schedule of Procedures. 2024. URL: https://codes.bupa.co.uk/ procedures (Accessed July 23, 2024).
12. Baastrup N. N., Buch A. K., Gundestrup A. K., et al. The incidence of venous thromboembolism after curative colon cancer surgery within an enhanced recovery after surgery program. Thromb Res. 2024;237:46-51.
13. Singh T., Lavikainen L. I., Halme A. L. E., et al. Timing of symptomatic venous thromboembolism after surgery: meta-analysis. Br J Surg. 2023;110:553561. doihttps://doi.org/10.1093/bjs/znad035.
14. Herb J. N., Iwai Y., Dunham L. N., Stitzenberg K. B. Persistent underuse of extended venous thromboembolism prophylaxis in patients undergoing major abdominal cancer operations. J Surg Oncol. 2024;129:436-443.
15. Mavros M. N., Johnson L. A., Schootman M., et al. Orcutt ST, Peng C, Martin BC. Adherence to extended venous thromboembolism prophylaxis and outcomes after complex gastrointestinal oncologic surgery. Ann Surg
16. Noureldin A., Ivankovic V., Delisle M., Wang T. F., Auer R. C., Carrier M. Extended-duration thromboprophylaxis following major abdominopelvic surgery – for everyone or selected cases only? Thromb Res. 2024;235:175-180.
17. Lewis-Lloyd CA, Humes DJ, West J, Peacock O, Crooks CJ. The duration and magnitude of postdischarge venous thromboembolism following colectomy. Ann Surg. 2022;276:e177-e184 doihttps://doi.org/10.1097/SLA.0000000000005563.
18. Auer R. C., Ott M., Karanicolas P., et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer
19. Sood D., Kuchta K., Paterakos P., et al. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive
20. Knoll W., Fergusson N., Ivankovic V. R., et al. Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature. Thromb Res 2021;204:114-122.
21. Heijkoop B., Nadi S., Spernat D., Kiroff G. Extended versus inpatient thromboprophylaxis with heparins following major open abdominopelvic surgery for malignancy: a systematic review of efficacy and safety. Perioper Med.
22. Somonova O. V., Antuh E. A., Vardanyan A. V. i dr. Prakticheskie rekomendacii po profilaktike i lecheniyu tromboembolicheskih oslozhneniy u onkologicheskih bol'nyh. Zlokachestvennye opuholi. 2022;12:159-
23. Schlick CJR, Liu JY, Yang AD, Bentrem DJ, Bilimoria KY, Merkow RP. Pre-operative, intraoperative, and post-operative factors associated with post-discharge venous thromboembolism following colorectal cancer resection. J
24. Katel'nickiy I. I., Nemirovich M. V., Livadnyaya E. S. Vybor metoda profilaktiki tromboticheskih oslozhneniy u pacientov s hirurgicheskimi zabolevaniyami zheludka vysokogo riska. Nauka molodyh (Eruditio
25. Hakimov D. P., Ortikboeva Sh. O., Fahriev Zh. A. i dr. Profilaktika tromboticheskih oslozhneniy v hirurgicheskoy praktike. Molodoy uchenyy. 2017;21(155): 172-175. URL: https:// moluch.ru/archive/155/43739/.
